Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FHXZC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $40,930
Award facts
- Contract value 100% obligated
- $40,930.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $40,930.24 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Dupixent 300 mg/2 mL pens (2 mL) with completion targeted for September 29, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
Dupixent is a specialty biologic medication used primarily for treating atopic conditions including atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps. This delivery order fulfills federal medical procurement needs within the Defense Health System, leveraging AmerisourceBergen's critical role as a primary pharmaceutical vendor for military and veteran healthcare. The company's extensive federal contract portfolio demonstrates consistent capability in delivering brand-name and generic medications, specialty pharmaceuticals, and medical supplies across multiple therapeutic domains to support Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FHXZC?
SPE2DB25FHXZC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FHXZC worth?
The government has obligated $40,930 on SPE2DB25FHXZC.
Is contract SPE2DB25FHXZC an order under another contract?
Yes. SPE2DB25FHXZC is a delivery order under SPE2DB24D2109, an indefinite delivery contract.
Was contract SPE2DB25FHXZC competed?
The extent of competition for SPE2DB25FHXZC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award